Pfizer Switches To Offense In Charity Co-Payment Suit Against HHS

Pfizer is one of 10 pharma companies that have reached settlements with the US Department of Justice over their relationships with co-pay assistance foundations. It now seeks a declaratory judgement that proposed programs for its heart drug tafamidis do not violate the anti-kickback statute.

PS2006_Co-Pay_194561387_1200.jpg
Pfizer sues HHS to implement copay assistance programs

Two years after reaching a settlement with the US Department of Justice over its relationship with a co-pay charity, Pfizer Inc. is going on the offense, challenging the government's position that such arrangements violate the Anti-Kickback Statue.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Medicare

More from Government Payers